What is ALMR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 1.75B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ALMR?

P/E (TTM) is n/a and 52-week range is $18.84 to $39.61 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ALMR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is Alamar Biosciences Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Fremont, California, US, 69.3M shares outstanding, ISIN US0109111056 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Alamar Biosciences Inc

$ALMR

Health Care · Life Sciences Tools & Services

Run Scenarios

$25.27

-2.47%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. The company is headquartered in Fremont, California. The company went IPO on 2026-04-17. The firm's proprietary NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology addresses the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, dynamic range and automation. Its integrated platform consists of proprietary instruments, consumables and analytical software that is designed to provide scientists with an end-to-end solution to precisely and consistently measure from one to hundreds of low-abundances and difficult-to-detect biomarkers across the continuum of discovery, translational research and ultimately diagnostics. Its instrument, the ARGO HT System, is designed to automate high-sensitivity and high-plex proteomics analysis and is available for research use only applications.

Website

alamarbio.com

IPO

2026-04-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)